Stop using now Drug recall · FDA · Published February 19, 2014

Atripla Recall: Foreign Substance in Drug Bottles

Gilead Sciences recalls Atripla tablets due to red silicone rubber particulates. Check lot numbers and expiration dates for affected bottles.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-1090-2014Drug Atripla ›

Stop using this now

Presence of Foreign Substance: Red Silicone Rubber Particulates are Present in Drug.

Take action

Contact the company

Recalling firmGilead Sciences, Inc.333 Lakeside Dr · Foster City, CA 94404-1147

✎ GovInfoNow plain-language explainer

Gilead Sciences is recalling 30-tablet bottles of Atripla because they may contain red silicone rubber particulates. The product was manufactured in Ireland and distributed nationwide, including Puerto Rico. No remedy or action steps are currently listed in the record. Read more at govinfonow.com/recall/46251-gilead-sciences-inc-recalls-atripla-efavirenz-600-mg-emtricitabine-200.

Source Summary by GovInfoNow · govinfonow.com/recall/46251-gilead-sciences-inc-recalls-atripla-efavirenz-600-mg-emtricitabine-200 · Updated October 13, 2026 · FDA enforcement record: FDA #D-1090-2014

Cite this page

“Atripla Recall: Foreign Substance in Drug Bottles.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46251-gilead-sciences-inc-recalls-atripla-efavirenz-600-mg-emtricitabine-200. Based on FDA recall #D-1090-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1090-2014%22&limit=1).

The FDA announced on Feb. 19, 2014, that Gilead Sciences Inc. voluntarily recalled Atripla tablets due to red silicone rubber particulates found in the drug. Owners should contact the company for a refund, according to the FDA.

How to tell if you have it

Brand: Atripla
Product: Atripla Tablets
NDC: 15584-0101-1
Lot codes: 002390, 002400
Expiration date: 02/17
Quantity: 39,223 bottles

The hazard

The recall addresses the presence of red silicone rubber particulates in the drug, according to the FDA.

Context

GovInfoNow's records show Gilead Sciences Inc. has 6 other recalls on record since Jan. 31, 2013. Other recent recalls of similar products include Taro Recalls Children's Ibuprofen Due to Foreign Substance (March 2, 2026), Guardian Drug Goodsense Ultra Strength Antacid Tablets Recall: Metallic Particles Hazard (May 28, 2026), and Heritage Pharma Recalls Clindamycin Oral Solution Due to Foreign Particles (July 30, 2026).

How to tell if you have this one

Check your bottle for NDC 15584-0101-1. Affected lots are 002390 and 002400 with an expiration date of 02/17. The product is Rx only, manufactured by Bristol-Myers Squibb & Gilead Sciences, LLC in Foster City, CA.

Brand
Atripla
Category
Drug

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “Nationwide including Puerto Rico.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 15 months after the firm started it.

Feb 19, 2014Firm started the recall
Feb 27, 2014FDA classified it Class III
Mar 5, 2014Published in FDA’s Enforcement Report
May 11, 2015FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/46251-gilead-sciences-inc-recalls-atripla-efavirenz-600-mg-emtricitabine-200">Atripla Recall: Foreign Substance in Drug Bottles (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-1090-2014 (February 19, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1090-2014 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.